Candida lusitaniae is a species of yeast in the genus Candida. Candida lusitaniae was first identified as a human pathogen in 1979. Candida lusitaniae was initially described as a rare cause of fungemia, with fewer than 30 cases reported between 1979 and 1990. However, there has been a marked increase in the number of recognized cases of candidemia due to this organism in the last two decades. Bone marrow transplantation and high-dose cytoreductive chemotherapy have both been identified as risk factors for infections with this organism.These patients are often neutropenic for extended periods of time, leaving them susceptible to bacterial and fungal infections, including Candidal infections. Some investigators have theorized that the widespread use of Amphotericin B empiric antifungal ther
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Candida lusitaniae (en)
- Candida lusitaniae (fr)
- Candida lusitaniae (pt)
- Clavispora lusitaniae (sv)
|
rdfs:comment
| - Candida lusitaniae est une espèce de levures peu fréquente. Elle peut causer chez les humains dont l'immunité est compromise des infections opportunistes essentiellement nosocomiales ou iatrogènes. C. lusitaniae a été initialement isolée du tube digestif des animaux à sang chaud. (fr)
- Clavispora lusitaniae är en svampart som beskrevs av Rodr. Mir. 1979. Clavispora lusitaniae ingår i släktet Clavispora och familjen Metschnikowiaceae. Inga underarter finns listade i Catalogue of Life. (sv)
- Candida lusitaniae is a species of yeast in the genus Candida. Candida lusitaniae was first identified as a human pathogen in 1979. Candida lusitaniae was initially described as a rare cause of fungemia, with fewer than 30 cases reported between 1979 and 1990. However, there has been a marked increase in the number of recognized cases of candidemia due to this organism in the last two decades. Bone marrow transplantation and high-dose cytoreductive chemotherapy have both been identified as risk factors for infections with this organism.These patients are often neutropenic for extended periods of time, leaving them susceptible to bacterial and fungal infections, including Candidal infections. Some investigators have theorized that the widespread use of Amphotericin B empiric antifungal ther (en)
- Candida lusitaniae é uma espécie de levedura do gênero Candida. A Candida lusitaniae foi identificada pela primeira vez como um patógeno humano em 1979. Candida lusitaniae foi inicialmente descrita como uma causa rara de fungemia, com menos de 30 casos relatados entre 1979 e 1990. No entanto, houve um aumento acentuado no número de casos reconhecidos de candidemia por esse organismo nas últimas duas décadas. O transplante de medula óssea e a quimioterapia citorredutora em altas doses foram identificados como fatores de risco para infecções por esse organismo. Esses pacientes são frequentemente neutropênicos por longos períodos de tempo, deixando-os suscetíveis a infecções bacterianas e fúngicas, incluindo infecções por Candida. Alguns pesquisadores teorizaram que o uso generalizado da tera (pt)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
authority
| |
genus
| |
species
| |
synonyms
| - Clavispora lusitaniae (en)
|
has abstract
| - Candida lusitaniae is a species of yeast in the genus Candida. Candida lusitaniae was first identified as a human pathogen in 1979. Candida lusitaniae was initially described as a rare cause of fungemia, with fewer than 30 cases reported between 1979 and 1990. However, there has been a marked increase in the number of recognized cases of candidemia due to this organism in the last two decades. Bone marrow transplantation and high-dose cytoreductive chemotherapy have both been identified as risk factors for infections with this organism.These patients are often neutropenic for extended periods of time, leaving them susceptible to bacterial and fungal infections, including Candidal infections. Some investigators have theorized that the widespread use of Amphotericin B empiric antifungal therapy selects for infections with Candida lusitaniae. (en)
- Candida lusitaniae est une espèce de levures peu fréquente. Elle peut causer chez les humains dont l'immunité est compromise des infections opportunistes essentiellement nosocomiales ou iatrogènes. C. lusitaniae a été initialement isolée du tube digestif des animaux à sang chaud. (fr)
- Candida lusitaniae é uma espécie de levedura do gênero Candida. A Candida lusitaniae foi identificada pela primeira vez como um patógeno humano em 1979. Candida lusitaniae foi inicialmente descrita como uma causa rara de fungemia, com menos de 30 casos relatados entre 1979 e 1990. No entanto, houve um aumento acentuado no número de casos reconhecidos de candidemia por esse organismo nas últimas duas décadas. O transplante de medula óssea e a quimioterapia citorredutora em altas doses foram identificados como fatores de risco para infecções por esse organismo. Esses pacientes são frequentemente neutropênicos por longos períodos de tempo, deixando-os suscetíveis a infecções bacterianas e fúngicas, incluindo infecções por Candida. Alguns pesquisadores teorizaram que o uso generalizado da terapia antifúngica empírica com Anfotericina B seleciona infecções por Candida lusitaniae. (pt)
- Clavispora lusitaniae är en svampart som beskrevs av Rodr. Mir. 1979. Clavispora lusitaniae ingår i släktet Clavispora och familjen Metschnikowiaceae. Inga underarter finns listade i Catalogue of Life. (sv)
|
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is foaf:primaryTopic
of | |